Selected research
Industry Research
PCR Cloning and Subcloning Services Industry Research Report 2026
Market perspective
The global PCR Cloning and Subcloning Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the PCR Cloning and Subcloning Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the PCR Cloning and Subcloning Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the PCR Cloning and Subcloning Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of PCR Cloning and Subcloning Services include GenScript, Eurofins Genomics, MCLAB, Tsingke Biotech, Synbio Technologies, 1st BASE, CD Biosynsis, Genetika Science and Beijing Generaybiotech co., Ltd, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global PCR Cloning and Subcloning Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to PCR Cloning and Subcloning Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PCR Cloning and Subcloning Services Market by Company
GenScript
Eurofins Genomics
MCLAB
Tsingke Biotech
Synbio Technologies
1st BASE
CD Biosynsis
Genetika Science
Beijing Generaybiotech co., Ltd
NorClone
Genecfps
Gentlegen
Shanghai Dynegene Technologies Co., Ltd
Sydlabs
OriGene
Thermo Fisher Scientific
Eton Bioscience
Innoprot
PCR Cloning and Subcloning Services Segment by Type
PCR Cloning Services
Subcloning Services
PCR Cloning and Subcloning Services Segment by Application
Basic Research
Biotechnology
Pharmaceutical
Others
PCR Cloning and Subcloning Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PCR Cloning and Subcloning Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PCR Cloning and Subcloning Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PCR Cloning and Subcloning Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of PCR Cloning and Subcloning Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PCR Cloning Services
- Subcloning Services
Applications
- Basic Research
- Biotechnology
- Pharmaceutical
- Others
Companies covered
- GenScript
- Eurofins Genomics
- MCLAB
- Tsingke Biotech
- Synbio Technologies
- 1st BASE
- CD Biosynsis
- Genetika Science
- Beijing Generaybiotech co., Ltd
- NorClone
- Genecfps
- Gentlegen
- Shanghai Dynegene Technologies Co., Ltd
- Sydlabs
- OriGene
- Thermo Fisher Scientific
- Eton Bioscience
- Innoprot
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 PCR Cloning and Subcloning Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 PCR Cloning Services
- 2.2.3 Subcloning Services
- 2.3 PCR Cloning and Subcloning Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Basic Research
- 2.3.3 Biotechnology
- 2.3.4 Pharmaceutical
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 PCR Cloning and Subcloning Services Breakdown Data by Type
- 3.1 Global PCR Cloning and Subcloning Services Historic Market Size by Type (2021-2026)
- 3.2 Global PCR Cloning and Subcloning Services Forecasted Market Size by Type (2027-2032)
4 PCR Cloning and Subcloning Services Breakdown Data by Application
- 4.1 Global PCR Cloning and Subcloning Services Historic Market Size by Application (2021-2026)
- 4.2 Global PCR Cloning and Subcloning Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global PCR Cloning and Subcloning Services Market Perspective (2021-2032)
- 5.2 Global PCR Cloning and Subcloning Services Growth Trends by Region
- 5.2.1 Global PCR Cloning and Subcloning Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 PCR Cloning and Subcloning Services Historic Market Size by Region (2021-2026)
- 5.2.3 PCR Cloning and Subcloning Services Forecasted Market Size by Region (2027-2032)
- 5.3 PCR Cloning and Subcloning Services Market Dynamics
- 5.3.1 PCR Cloning and Subcloning Services Industry Trends
- 5.3.2 PCR Cloning and Subcloning Services Market Drivers
- 5.3.3 PCR Cloning and Subcloning Services Market Challenges
- 5.3.4 PCR Cloning and Subcloning Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top PCR Cloning and Subcloning Services Players by Revenue
- 6.1.1 Global Top PCR Cloning and Subcloning Services Players by Revenue (2021-2026)
- 6.1.2 Global PCR Cloning and Subcloning Services Revenue Market Share by Players (2021-2026)
- 6.2 Global PCR Cloning and Subcloning Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of PCR Cloning and Subcloning Services Head Office and Area Served
- 6.4 Global PCR Cloning and Subcloning Services Players, Product Type & Application
- 6.5 Global PCR Cloning and Subcloning Services Manufacturers Established Date
- 6.6 Global PCR Cloning and Subcloning Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America PCR Cloning and Subcloning Services Market Size (2021-2032)
- 7.2 North America PCR Cloning and Subcloning Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America PCR Cloning and Subcloning Services Market Size by Country (2021-2026)
- 7.4 North America PCR Cloning and Subcloning Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe PCR Cloning and Subcloning Services Market Size (2021-2032)
- 8.2 Europe PCR Cloning and Subcloning Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe PCR Cloning and Subcloning Services Market Size by Country (2021-2026)
- 8.4 Europe PCR Cloning and Subcloning Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific PCR Cloning and Subcloning Services Market Size (2021-2032)
- 9.2 Asia-Pacific PCR Cloning and Subcloning Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific PCR Cloning and Subcloning Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific PCR Cloning and Subcloning Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America PCR Cloning and Subcloning Services Market Size (2021-2032)
- 10.2 South America PCR Cloning and Subcloning Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America PCR Cloning and Subcloning Services Market Size by Country (2021-2026)
- 10.4 South America PCR Cloning and Subcloning Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa PCR Cloning and Subcloning Services Market Size (2021-2032)
- 11.2 Middle East & Africa PCR Cloning and Subcloning Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa PCR Cloning and Subcloning Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa PCR Cloning and Subcloning Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 GenScript
- 12.1.1 GenScript Company Information
- 12.1.2 GenScript Business Overview
- 12.1.3 GenScript Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.1.4 GenScript PCR Cloning and Subcloning Services Product Portfolio
- 12.1.5 GenScript Recent Developments
- 12.2 Eurofins Genomics
- 12.2.1 Eurofins Genomics Company Information
- 12.2.2 Eurofins Genomics Business Overview
- 12.2.3 Eurofins Genomics Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.2.4 Eurofins Genomics PCR Cloning and Subcloning Services Product Portfolio
- 12.2.5 Eurofins Genomics Recent Developments
- 12.3 MCLAB
- 12.3.1 MCLAB Company Information
- 12.3.2 MCLAB Business Overview
- 12.3.3 MCLAB Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.3.4 MCLAB PCR Cloning and Subcloning Services Product Portfolio
- 12.3.5 MCLAB Recent Developments
- 12.4 Tsingke Biotech
- 12.4.1 Tsingke Biotech Company Information
- 12.4.2 Tsingke Biotech Business Overview
- 12.4.3 Tsingke Biotech Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.4.4 Tsingke Biotech PCR Cloning and Subcloning Services Product Portfolio
- 12.4.5 Tsingke Biotech Recent Developments
- 12.5 Synbio Technologies
- 12.5.1 Synbio Technologies Company Information
- 12.5.2 Synbio Technologies Business Overview
- 12.5.3 Synbio Technologies Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.5.4 Synbio Technologies PCR Cloning and Subcloning Services Product Portfolio
- 12.5.5 Synbio Technologies Recent Developments
- 12.6 1st BASE
- 12.6.1 1st BASE Company Information
- 12.6.2 1st BASE Business Overview
- 12.6.3 1st BASE Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.6.4 1st BASE PCR Cloning and Subcloning Services Product Portfolio
- 12.6.5 1st BASE Recent Developments
- 12.7 CD Biosynsis
- 12.7.1 CD Biosynsis Company Information
- 12.7.2 CD Biosynsis Business Overview
- 12.7.3 CD Biosynsis Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.7.4 CD Biosynsis PCR Cloning and Subcloning Services Product Portfolio
- 12.7.5 CD Biosynsis Recent Developments
- 12.8 Genetika Science
- 12.8.1 Genetika Science Company Information
- 12.8.2 Genetika Science Business Overview
- 12.8.3 Genetika Science Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.8.4 Genetika Science PCR Cloning and Subcloning Services Product Portfolio
- 12.8.5 Genetika Science Recent Developments
- 12.9 Beijing Generaybiotech co., Ltd
- 12.9.1 Beijing Generaybiotech co., Ltd Company Information
- 12.9.2 Beijing Generaybiotech co., Ltd Business Overview
- 12.9.3 Beijing Generaybiotech co., Ltd Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.9.4 Beijing Generaybiotech co., Ltd PCR Cloning and Subcloning Services Product Portfolio
- 12.9.5 Beijing Generaybiotech co., Ltd Recent Developments
- 12.10 NorClone
- 12.10.1 NorClone Company Information
- 12.10.2 NorClone Business Overview
- 12.10.3 NorClone Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.10.4 NorClone PCR Cloning and Subcloning Services Product Portfolio
- 12.10.5 NorClone Recent Developments
- 12.11 Genecfps
- 12.11.1 Genecfps Company Information
- 12.11.2 Genecfps Business Overview
- 12.11.3 Genecfps Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.11.4 Genecfps PCR Cloning and Subcloning Services Product Portfolio
- 12.11.5 Genecfps Recent Developments
- 12.12 Gentlegen
- 12.12.1 Gentlegen Company Information
- 12.12.2 Gentlegen Business Overview
- 12.12.3 Gentlegen Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.12.4 Gentlegen PCR Cloning and Subcloning Services Product Portfolio
- 12.12.5 Gentlegen Recent Developments
- 12.13 Shanghai Dynegene Technologies Co., Ltd
- 12.13.1 Shanghai Dynegene Technologies Co., Ltd Company Information
- 12.13.2 Shanghai Dynegene Technologies Co., Ltd Business Overview
- 12.13.3 Shanghai Dynegene Technologies Co., Ltd Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.13.4 Shanghai Dynegene Technologies Co., Ltd PCR Cloning and Subcloning Services Product Portfolio
- 12.13.5 Shanghai Dynegene Technologies Co., Ltd Recent Developments
- 12.14 Sydlabs
- 12.14.1 Sydlabs Company Information
- 12.14.2 Sydlabs Business Overview
- 12.14.3 Sydlabs Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.14.4 Sydlabs PCR Cloning and Subcloning Services Product Portfolio
- 12.14.5 Sydlabs Recent Developments
- 12.15 OriGene
- 12.15.1 OriGene Company Information
- 12.15.2 OriGene Business Overview
- 12.15.3 OriGene Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.15.4 OriGene PCR Cloning and Subcloning Services Product Portfolio
- 12.15.5 OriGene Recent Developments
- 12.16 Thermo Fisher Scientific
- 12.16.1 Thermo Fisher Scientific Company Information
- 12.16.2 Thermo Fisher Scientific Business Overview
- 12.16.3 Thermo Fisher Scientific Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.16.4 Thermo Fisher Scientific PCR Cloning and Subcloning Services Product Portfolio
- 12.16.5 Thermo Fisher Scientific Recent Developments
- 12.17 Eton Bioscience
- 12.17.1 Eton Bioscience Company Information
- 12.17.2 Eton Bioscience Business Overview
- 12.17.3 Eton Bioscience Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.17.4 Eton Bioscience PCR Cloning and Subcloning Services Product Portfolio
- 12.17.5 Eton Bioscience Recent Developments
- 12.18 Innoprot
- 12.18.1 Innoprot Company Information
- 12.18.2 Innoprot Business Overview
- 12.18.3 Innoprot Revenue in PCR Cloning and Subcloning Services Business (2021-2026)
- 12.18.4 Innoprot PCR Cloning and Subcloning Services Product Portfolio
- 12.18.5 Innoprot Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst